AbbVie

News

AbbVie raises hopes for blood cancer patients

AbbVie has filed its Venclexta (venetoclax) for a new use that it hopes could change the treatment of one of the most aggressive cancers – acute myeloid leukaemia (AML).

News

AbbVie leads $53m investment macrophage cancer tech

A duo of University of Pennsylvania scientists have stepped out with multi-million dollar backing from investors including AbbVie, on a mission to kill tumour cells using re-engineered macrophag

Partner Content

Partner Content

New Speakers from Roche & Imperial College announced for...

Roche to join ADMET conference this July in London

News

Amid tough competition, Novartis makes case for rheumatology...

Swiss pharma hopes to bounce back from Q1 sales disappointment

Views & Analysis

Top pharmaceutical companies in the world in 2017

The rankings of the top pharmaceutical companies in the world in 2017 presented a mixed picture, with stability for some of the 25 largest firms as others saw their value fall.

News

More good news for AbbVie in rheumatoid arthritis

AbbVie has reported positive top-line results for its oral JAK1-selective inhibitor in rheumatoid arthritis (RA), bringing it closer to a potential new early treatment option for patients.

AbbVie raises hopes for blood cancer patients

AbbVie leads $53m investment macrophage cancer tech

New Speakers from Roche & Imperial College announced for...

Amid tough competition, Novartis makes case for rheumatology...

Top pharmaceutical companies in the world in 2017

More good news for AbbVie in rheumatoid arthritis

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

AbbVie

Editor's Picks